|
SONN Sonnet Biotherapeutics Holdings Inc 1106838 |
| Income Statement |
|
Revenue
|
form10-k
|
18,626 |
|
Net Income
|
form10-k
|
-7,437,232 |
|
Profit Margin
|
|
-39929.3% |
| Balance Sheet |
|
Current Assets
|
2,117,943 |
|
Assets
|
2,771,030 |
|
Current Liabilities
|
3,210,196 |
|
Liabilities
|
3,256,769 |
|
Equity
|
-485,739 |
|
Shares Out
|
5,203,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-8,607,723 |
|
Investing Cash Flow
|
-12,000 |
| Market Analysis |
Market Cap
|
4,984,993 |
|
Price
|
1.54 |
|
PB
|
584.62 |
|
EPS
|
-3.02 |
|
PS
|
66.91 |
|
FCF
|
-8,619,723 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SONN documents filed with the SEC.
SONN Filings
Clear
